化学
苯并噻唑
生物利用度
单糖
部分
药理学
结构-活动关系
结合位点
立体化学
生物化学
组合化学
体外
医学
作者
Chunjian Liu,Wei Wang,Jianxin Feng,Brett R. Beno,Thiruvenkadam Raja,Jacob J. Swidorski,Raju K. V. L. P. Manepalli,Muthalagu Vetrichelvan,Prasada Rao Jalagam,Satheesh K. Nair,Anuradha Gupta,Manoranjan Panda,Kaushik Ghosh,Jinal K. Shukla,Harinath Sale,Devang Shah,Shashyendra Singh Gautam,Dipal Patel,Arvind Mathur,Bruce A. Ellsworth,Dong Cheng,Alicia Regueiro‐Ren
标识
DOI:10.1016/j.bmc.2024.117638
摘要
As a result of our continued efforts to pursue Gal-3 inhibitors that could be used to fully evaluate the potential of Gal-3 as a therapeutic target, two novel series of benzothiazole derived monosaccharides as potent (against both human and mouse Gal-3) and orally bioavailable Gal-3 inhibitors, represented by 4 and 5, respectively, were identified. These discoveries were made based on proposals that the benzothiazole sulfur atom could interact with the carbonyl oxygen of G182/G196 in h/mGal-3, and that the anomeric triazole moiety could be modified into an N-methyl carboxamide functionality. The interaction between the benzothiazole sulfur and the carbonyl oxygen of G196 in mGal-3 was confirmed by an X-ray co-crystal structure of early lead 9, providing a rare example of using a S···O binding interaction for drug design. It was found that for both the series, methylation of 3-OH in the monosaccharides caused no loss in h & mGal-3 potencies but significantly improved permeability of the molecules.
科研通智能强力驱动
Strongly Powered by AbleSci AI